На этой странице перечислены больницы направления «Гинекология» (включая Pessary Placement) в Мумбаи, Индия, включая Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai и другие.
Спросите нас о «Pessary Placement» в Мумбаи, Индия
Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.
Сравните 17 аккредитованных больниц (Гинекология) в Мумбаи, Индия
Рекомендуем🇮🇳 Nanavati Super Specialty Hospital
Больница занимает 1-е место в этом списке по указанному рейтингу (5/5, 12 отзывов).
🇮🇳 Kokilaben Dhirubhai Ambani Hospital
Больница занимает 2-е место в этом списке по указанному рейтингу (4.8/5, 1800 отзывов).
🇮🇳 Tata Memorial Hospital
Больница занимает 3-е место в этом списке по указанному рейтингу (4.8/5, 2500 отзывов).
🇮🇳 Apollo Hospitals, Navi Mumbai
Больница занимает 4-е место в этом списке по указанному рейтингу (4.8/5, 512 отзывов).
🇮🇳 Gleneagles Hospital, Mumbai
Больница занимает 5-е место в этом списке по указанному рейтингу (4.8/5, 615 отзывов).
🇮🇳 Lilavati Hospital And Research Centre
Больница занимает 6-е место в этом списке по указанному рейтингу (4.8/5, 724 отзывов).
🇮🇳 Jaslok Hospital
Больница занимает 7-е место в этом списке по указанному рейтингу (4.6/5, 129 отзывов).
🇮🇳 Gleneagles Global Hospitals (Global Hospitals)
Больница занимает 8-е место в этом списке по указанному рейтингу (4.6/5, 183 отзывов).
🇮🇳 Medicover Hospital, Navi Mumbai
Больница занимает 9-е место в этом списке по указанному рейтингу (4.6/5, 143 отзывов).
🇮🇳 KIMS Hospitals, Thane
Больница занимает 10-е место в этом списке по указанному рейтингу (4.6/5, 58 отзывов).
🇮🇳 Fortis Hospital, Mulund
Больница занимает 11-е место в этом списке по указанному рейтингу (4.5/5, 79 отзывов).
🇮🇳 Fortis Hiranandani Hospital, Vashi
Больница занимает 12-е место в этом списке по указанному рейтингу (4.5/5, 83 отзывов).
🇮🇳 Wockhardt Hospital
Больница занимает 13-е место в этом списке по указанному рейтингу (4.4/5, 30 отзывов).
🇮🇳 Wockhardt Super Speciality Hospital
Больница занимает 14-е место в этом списке по указанному рейтингу (4.4/5, 48 отзывов).
🇮🇳 S. L. Raheja Hospital
Больница занимает 15-е место в этом списке по указанному рейтингу (4.4/5, 121 отзывов).
🇮🇳 Saifee Hospital
Больница занимает 16-е место в этом списке по указанному рейтингу (4.3/5, 97 отзывов).
🇮🇳 Dr. L H Hiranandani Hospital
Больница занимает 17-е место в этом списке по указанному рейтингу (4.3/5, 141 отзывов).
Как мы выбираем эти больницы
Больница появляется на этой странице, если направление «Гинекология» указано среди её специализаций и она находится в Мумбаи, Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Как выбрать лучшую больницу для «pessary placement» в Мумбаи, Индия?
Выбор подходящей больницы для «pessary placement» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:
Международная аккредитация
Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.
Специализация
Убедитесь, что в больнице есть отделение, специализирующееся на «Гинекология», а не только общая помощь.
Мощность и опыт
Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.
Прозрачность стоимости
Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.
Что нужно знать о процедуре «Pessary Placement»
Pessary fitting is a non-surgical, office-based gynecological procedure used to mechanically support pelvic organs affected by pelvic organ prolapse (POP) or stress urinary incontinence (SUI), offering an evidence-based alternative to reconstructive surgery with a clinical success rate of 70–90% in appropriately selected patients. International patients choose India and the UAE through GAF Healthcare for access to subspecialty urogynecologists, advanced pessary sizing technology, and comprehensive follow-up protocols at internationally accredited centers — all at a fraction of Western healthcare costs. GAF Healthcare coordinates the entire care pathway, from pre-travel diagnostic review and specialist matching to post-fitting follow-up scheduling and safe return travel planning. Hospital Stay: 0–1 days (outpatient procedure; overnight observation rarely required) • Total Stay in Country (Fit-to-Fly): 1–3 days (most patients are cleared for international travel within 24–72 hours of successful fitting and initial comfort confirmation) • Success Rate: 70–90% (successful pessary fitting and sustained use at 12 months; varies by prolapse stage, patient anatomy, and pessary type)
Clinical Overview
Pelvic organ prolapse (POP) occurs when the structural integrity of the pelvic floor — comprising the levator ani muscle complex, endopelvic fascia, and uterosacral-cardinal ligament system — is compromised, allowing the bladder (cystocele), rectum (rectocele), uterus, or vaginal apex (vault prolapse) to descend into or beyond the vaginal canal. The condition is staged using the internationally validated POP-Q (Pelvic Organ Prolapse Quantification) system, ranging from Stage I (descent above the hymen) to Stage IV (complete procidentia). Symptoms include pelvic pressure, a sensation of vaginal bulge, voiding dysfunction, incomplete bladder emptying, defecatory difficulty, and coital discomfort, all of which significantly impair quality of life and are measurable via validated instruments such as the PFDI-20 (Pelvic Floor Distress Inventory) and PFIQ-7. A pessary is a medical-grade silicone or latex device inserted into the vaginal vault to provide mechanical support to the prolapsed pelvic structures without surgical intervention. Modern pessaries are manufactured from inert, body-safe silicone and are available in over 20 distinct anatomical configurations — including ring, Gellhorn, cube, donut, Shaatz, and Hodge designs — selected based on prolapse compartment, severity, vaginal dimensions, and the patient's capacity for self-management. The fitting process involves a systematic trial of device types and sizes guided by pelvic examination, with adequacy confirmed by the ability to perform a Valsalva maneuver without expulsion and to void without residual obstruction. Concurrent stress urinary incontinence is addressed with incontinence-specific pessaries such as the ring-with-knob or dish-with-support variants. The standard of care at GAF Healthcare's partner institutions integrates pre-fitting urodynamic assessment where indicated, 3D pelvic floor ultrasonography or dynamic MRI defecography for complex multi-compartment prolapse, and structured follow-up at 2 weeks, 6 weeks, and every 3–6 months thereafter. Pessary therapy is supported by a robust evidence base, including data from the OPTIMAL trial (Operations and Pelvic Muscle Training in the Management of Apical Support Loss), positioning it as the first-line non-surgical intervention per guidelines from the American Urogynecologic Society (AUGS), the International Urogynecological Association (IUGA), and RCOG.
Who is a Candidate?
• ELIGIBLE PATIENTS: • Women with symptomatic POP-Q Stage II–IV pelvic organ prolapse (cystocele, rectocele, uterine prolapse, or vaginal vault prolapse) who prefer to avoid or defer surgical reconstruction • Patients with stress urinary incontinence (SUI) not responding adequately to pelvic floor muscle training (Kegel exercises) seeking a bridging or permanent non-surgical option • Elderly or medically complex patients who are high-risk surgical candidates due to cardiovascular disease, diabetes, obesity (BMI >35), or anticoagulation therapy • Women in the reproductive years wishing to preserve uterine function or planning future pregnancies • Patients awaiting surgical scheduling who require interim symptomatic relief • Post-hysterectomy vaginal vault prolapse (suitable for supportive pessary types such as Gellhorn or cube) • Women with incomplete bladder emptying (post-void residual >100 mL) secondary to advanced anterior wall prolapse causing urethral kinking • REQUIRED DIAGNOSTICS (pre-fitting evaluation): • Detailed pelvic examination with POP-Q staging • Urine dipstick and midstream urine culture (to exclude active UTI before fitting) • Post-void residual urine volume measurement (bladder scan or catheterisation) • Urodynamic studies (multichannel cystometry) — indicated for mixed incontinence, voiding dysfunction, or pre-surgical planning • 3D/4D transperineal pelvic floor ultrasound — for levator ani integrity assessment, hiatal dimensions, and pessary sizing guidance • Dynamic pelvic MRI (MR defecography) — reserved for complex multi-compartment prolapse or suspected enterocele/sigmoidocele • Cervical cytology (Pap smear) — must be current per national screening guidelines before initiation of pessary therapy • Vaginal pH and atrophic vaginitis assessment — genitourinary syndrome of menopause (GSM) may require concurrent topical oestrogen therapy for optimal pessary tolerance • CONTRAINDICATIONS: • Active vaginal, cervical, or pelvic infection (including bacterial vaginosis, trichomoniasis, or pelvic inflammatory disease) • Severe vaginal stenosis or obliterative vaginitis precluding safe device placement • Known allergy or sensitivity to medical-grade silicone or latex • Patients unable or unwilling to attend scheduled follow-up for pessary maintenance (high risk of erosion, fistula formation, and incarceration with neglected pessaries) • Active vaginal or cervical malignancy • Genital fistula (vesicovaginal, rectovaginal) — requires surgical correction first
Treatment Options & Approaches
PESSARY TYPE SELECTION — EVIDENCE-BASED CLASSIFICATION: The choice of pessary design is the cornerstone of successful fitting and is guided by prolapse compartment, POP-Q stage, vaginal anatomy, and patient self-management capability. 1. RING PESSARY (with or without support membrane): The first-line device for Stage II–III anterior and uterine prolapse. Available in sizes 0–13 (diameter 44–113 mm). The ring-with-support variant manages concurrent cystocele; the ring-with-knob variant provides urethral compression for coexistent SUI. Self-removal-capable; ideal for sexually active patients. 2. GELLHORN PESSARY: The gold-standard device for advanced (Stage III–IV) or post-hysterectomy vault prolapse. Its concave disc-and-stem design creates a suction mechanism providing robust apical support. Requires clinician removal for cleaning; recommended follow-up every 3 months. 3. CUBE PESSARY: Reserved for complete procidentia or cases where ring and Gellhorn devices have failed. Retention is achieved via six suction-cup faces against the vaginal walls. Requires daily self-removal and cleaning; highest risk of vaginal wall pressure effects if neglected. 4. DISH/DONUT PESSARY: Used for severe anterior compartment defects and high-grade cystocele where a ring pessary provides insufficient anterior support. 5. HODGE/SMITH PESSARY: Specifically designed for uterine retroversion with associated prolapse or for SUI in patients with a retroverted uterus. 6. INCONTINENCE DISH WITH SUPPORT: A flat, membrane-filled design providing simultaneous urethral support and bladder neck elevation; preferred for dominant SUI with mild cystocele. FITTING METHODOLOGY — STEP-BY-STEP CLINICAL PROCESS: Fitting is conducted as a structured trial. The clinician estimates pessary size using vaginal examination (measuring the diagonal distance from the posterior fornix to the pubic symphysis). The trial pessary is inserted into the posterior vaginal fornix, and the patient is asked to ambulate, perform Valsalva maneuvers, and attempt voiding. A correctly fitted pessary: (a) is retained during Valsalva, (b) allows passage of one examining finger between device and vaginal wall, (c) permits comfortable voiding with post-void residual <100 mL, and (d) is not perceived by the patient during normal activity. Multiple sizes and types may be trialled in one session. ADJUNCT TECHNOLOGIES AVAILABLE AT GAF PARTNER CENTERS: • 3D/4D Transperineal Ultrasound-Guided Sizing: Real-time visualisation of the levator hiatus and pessary position, reducing the number of trial fittings needed and optimising device selection — particularly valuable in patients with prior pelvic surgery or atypical anatomy. • Digital Pelvic Floor Assessment Tools: Perineometry (intravaginal pressure biofeedback) to quantify levator ani contractile strength, guiding concurrent PFMT prescription. • Concurrent Topical Oestrogen Therapy: For patients with genitourinary syndrome of menopause (GSM), topical oestradiol or prasterone (intravaginal DHEA) is co-prescribed to improve vaginal epithelial integrity, reduce erosion risk, and optimise pessary comfort — an evidence-based adjunct supported by NAMS and IUGA guidelines. • Urodynamics Suite: Full multichannel urodynamic testing (cystometry, pressure-flow studies, urethral pressure profilometry) for patients with mixed or occult incontinence, preventing unmasking of stress incontinence post-fitting without a management plan.
Восстановление
STEP 1 — PRE-TRAVEL CONSULTATION (Weeks 1–2 before travel): GAF Healthcare coordinates a secure telemedicine consultation with a subspecialty urogynecologist at the destination center. The patient submits prior imaging (pelvic ultrasound, MRI if available), urodynamic reports, obstetric history, BMI, and a completed PFDI-20 symptom questionnaire. The specialist reviews POP-Q staging, recommends the likely pessary type(s) for trial, and orders any outstanding diagnostics to be completed on arrival. A personalised care plan and cost estimate are issued. STEP 2 — ARRIVAL & DIAGNOSTIC WORKUP (Day 1): The patient arrives at the destination city. GAF Healthcare provides airport transfer to the hospital or affiliated hotel. On Day 1, the urogynecology team conducts: (a) clinical pelvic examination with formal POP-Q staging, (b) 3D transperineal ultrasound for levator hiatus measurement and prolapse characterisation, (c) post-void residual bladder scan, (d) midstream urine culture, and (e) urodynamic assessment if mixed incontinence is present. Results are reviewed same-day. STEP 3 — PESSARY FITTING SESSION (Day 1 or Day 2, Duration: 30–60 minutes): The fitting is performed in the urogynecology outpatient suite — no anaesthesia, no incision, no hospital admission required. The clinician systematically trials pessary types and sizes using vaginal examination landmarks and ultrasound guidance where available. Patient comfort, retention during Valsalva, and voiding function are all confirmed before the session concludes. A pessary care instruction session is provided, including self-removal technique (for ring-type devices), cleaning protocols (mild soap and water; avoid disinfectants), and symptom red-flag education (unusual discharge, bleeding, inability to void, pelvic pain). STEP 4 — IMMEDIATE POST-FITTING OBSERVATION (Day 2): A follow-up assessment is scheduled 24 hours post-fitting to confirm: (a) absence of voiding dysfunction or urinary retention, (b) patient comfort during normal daily activities, (c) no de novo or worsened stress incontinence (unmasking phenomenon), and (d) device retention. Minor adjustments — such as upsizing, downsizing, or switching pessary type — are made at this visit if required. STEP 5 — FIT-TO-FLY CLEARANCE (Day 2–3): Once comfortable voiding, device retention, and absence of complications are confirmed, the urogynecologist issues fit-to-fly documentation. The patient is provided with: a detailed pessary record card (device type, size, brand, insertion date), a structured follow-up schedule (2-week virtual check-in with GAF-coordinated telemedicine; 6-week in-person or virtual review), written emergency contact protocols, and a prescription for topical oestrogen where indicated. STEP 6 — ONGOING REMOTE MANAGEMENT (Weeks 2–12): GAF Healthcare facilitates virtual follow-up consultations with the treating urogynecologist. Patients are advised to attend in-person pessary maintenance (cleaning and inspection by a clinician) every 3–6 months, either locally at a trained provider coordinated by GAF or at the original treatment center during a return visit. Annual review includes repeat POP-Q staging and pessary replacement as needed (typically every 2–5 years depending on device type).
Возможные риски
Pessary fitting is one of the safest gynecological interventions, with a serious complication rate of less than 2% in properly monitored patients. However, clinicians and patients should be aware of the following procedure-specific risks and considerations: Vaginal erosion and ulceration: The most clinically significant complication, occurring in approximately 8–9% of long-term users (>12 months), most commonly with neglected pessaries or in patients with untreated genitourinary syndrome of menopause (GSM). Risk is mitigated by concurrent topical oestrogen therapy and adherence to 3–6 monthly follow-up. Urinary retention and voiding dysfunction: Occurs in approximately 5–8% of patients immediately post-fitting, typically due to urethral compression from an oversized device. Managed by downsizing or changing pessary type; resolves within 24 hours of adjustment. Unmasking of occult stress urinary incontinence: Correction of the prolapse-related urethral kinking may expose latent SUI in up to 36% of patients (CARE trial data). Pre-fitting urodynamics are recommended to counsel patients appropriately and plan concurrent incontinence management. Vaginal discharge and malodour: A common side effect of pessary use, often representing normal vaginal microbiome disruption rather than infection. Bacterial vaginosis is more prevalent in pessary users; managed with metronidazole or clindamycin as indicated. Pessary incarceration: An uncommon but serious complication associated with neglected pessaries (months to years without removal). Incarcerated Gellhorn or cube pessaries may require examination under anaesthesia for removal. This risk is eliminated by strict follow-up adherence. Vesicovaginal or rectovaginal fistula formation: Extremely rare (<0.1%) and invariably associated with severely neglected, forgotten pessaries in patients without regular follow-up — not a risk of properly managed pessary therapy. Fitting failure / inability to retain pessary: Occurs in approximately 10–30% of patients during the initial fitting session, most commonly in those with a wide genital hiatus (levator ani avulsion injury), prior extensive pelvic surgery, or very advanced prolapse. These patients may require a different pessary type or surgical consultation. GAF Healthcare ensures all patients are counselled on realistic expectations before travel.
Почему GAF Healthcare
GAF Healthcare provides a fully integrated, non-medical support infrastructure designed to eliminate logistical barriers for international patients traveling for pessary fitting — an outpatient procedure that typically requires only 2–3 days in-country. INDIA — VISA & ENTRY: Most international patients qualify for the Indian e-Medical Visa (e-MV), obtainable online within 3–5 business days. GAF Healthcare provides a formal invitation letter from the treating hospital, required for visa application, along with the patient's preliminary diagnosis documentation. The e-Medical Visa permits a stay of up to 60 days and allows two attendants on e-Medical Attendant Visas. Our team guides patients through the complete application portal. UAE (DUBAI / ABU DHABI) — VISA & ENTRY: Passport holders from over 50 countries (including EU, UK, US, Canada, Australia, GCC nationals, and many Asian countries) receive visa-on-arrival or visa-free access to the UAE for 30–90 days. For nationals requiring advance visas, GAF Healthcare coordinates a medical treatment visa through the Dubai Health Authority (DHA) or Abu Dhabi Health Services Company (SEHA) affiliated hospitals. Processing is typically 3–5 business days. AIRPORT TRANSFERS & GROUND LOGISTICS: GAF Healthcare arranges private, air-conditioned airport-to-hospital and hospital-to-hotel transfers for the patient and up to two attendants. All vehicles are equipped for comfortable patient transport, with wheelchair-accessible options available on request. DEDICATED MULTILINGUAL CASE COORDINATORS: Each patient is assigned a personal GAF Healthcare case coordinator fluent in the patient's language (Arabic, Russian, French, Hindi, and other languages available). The coordinator accompanies the patient to all consultations, facilitates translation with the clinical team, and serves as the primary point of contact for any queries 24/7 during the in-country stay. ACCOMMODATION: GAF Healthcare has negotiated partner rates at medical-adjacent hotels and serviced apartments within 5–15 minutes of all partner hospitals in Mumbai, Delhi, Chennai, Hyderabad (India) and Dubai, Abu Dhabi (UAE). Rooms are booked for both the patient and one attendant as standard. Extended-stay apartments with kitchen facilities are available for patients who require longer diagnostic workups. POST-RETURN TELEMEDICINE CONTINUITY: GAF Healthcare schedules and facilitates virtual follow-up consultations at the 2-week and 6-week marks post-fitting, using a secure, HIPAA-compliant video consultation platform. Pessary maintenance records and clinical notes are shared with the patient's home country gynecologist upon request, ensuring seamless continuity of care.
Частые вопросы о процедуре «Pessary Placement»
What is the cost of pessary fitting in India compared to the UAE?
How long do I need to stay in the country before I am fit to fly home after pessary fitting?
What is the success rate of pessary fitting, and how long does a pessary last?
Похожие страницы
Как GAF Healthcare помогает выбрать лучшую больницу для «pessary placement» в Мумбаи, Индия
Найдите лучшие больницы для «pessary placement» в Мумбаи, Индия
На этой странице представлено 17 больниц в Мумбаи, Индия, чтобы вы могли сравнить аккредитацию и специализации в одном месте.
Поддержка, когда она нужна
Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.
Прозрачные, всё включено цены
Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.
Организация визы, поездки и проживания
После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.
Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.
Частые вопросы о «Pessary Placement» в Мумбаи, Индия
Сколько больниц направления «Гинекология» представлено в Мумбаи, Индия?
Как вы выбираете больницы для списка?
Сколько стоит лечение в Мумбаи, Индия?
Следующий шаг
Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Pessary Placement» в Мумбаи, Индия.
Свяжитесь с нами, если заметите неточность на этой странице.